SCHEMBL7977397

SCHEMBL7977397

Cc1ccc(NCl)c2ccccc12

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.59
CYP2A6 P11509 3/20 0.46
ALDH1A1 P00352 1/20 0.39
SLC40A1 Q9NP59 1/20 0.38
IDO1 P14902 5/20 0.38
TSHR P16473 2/20 0.37
KEAP1 Q14145 1/20 0.36
NFE2L2 Q16236 1/20 0.36
PSMD14 O00487 1/20 0.34
COPS5 Q92905 1/20 0.34
SLC6A2 P23975 1/20 0.34
HTT P42858 1/20 0.34
MEN1 O00255 1/20 0.34
GAA P10253 1/20 0.34
G6PD P11413 1/20 0.34
KMT2A Q03164 1/20 0.34
ACHE P22303 1/20 0.33
GRIN2D O15399 1/20 0.33
GRIN3B O60391 1/20 0.33
GRIN1 Q05586 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19849964 0.81 CYP1A2 (0.65) CYP1A2CYP2A6ALDH1A1SLC40A1IDO1
SCHEMBL1755235 0.79 CYP1A2 (0.62) CYP1A2CYP2A6ALDH1A1SLC40A1IDO1
SCHEMBL6631371 0.77 CYP1A2 (0.59) CYP1A2CYP2A6ALDH1A1SLC40A1IDO1
SCHEMBL1921284 0.77 CYP1A2 (0.59) CYP1A2CYP2A6ALDH1A1SLC40A1IDO1
SCHEMBL29447796 0.77 CYP1A2 (1.00) CYP1A2CYP2A6ALDH1A1TSHRPSMD14
SCHEMBL29363045 0.77 CYP1A2 (1.00) CYP1A2CYP2A6ALDH1A1TSHRPSMD14
SCHEMBL161370 0.77 CYP1A2 (1.00) CYP1A2CYP2A6ALDH1A1TSHRPSMD14
SCHEMBL1921282 0.76 CYP1A2 (0.56) CYP1A2CYP2A6ALDH1A1IDO1TSHR
SCHEMBL1455006 0.74 GAA (0.65) CYP1A2CYP2A6ALDH1A1TSHRSLC6A2
SCHEMBL20375316 0.74 IDO1 (0.63) CYP1A2CYP2A6ALDH1A1SLC40A1IDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010005534-A2 PROTEASOME INHIBITORS FOR SELECTIVELY INDUCING APOPTOSIS IN CANCER CELLS H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE, INC. (US) 2010-01-14 WO disclosed